Dietary Supplement vs Food vs Medicine: Where the Boundaries Matter for Consumers

The same compound can be classified as a food, a dietary supplement, or a medicine depending on dose, formulation, and intended use. This is not a technicality — the classification determines the evidence requirements before sale, the permitted health claims, the safety testing standard, and the regulatory oversight. Understanding these boundaries helps consumers interpret what product claims actually mean.

The Three-Category Framework

Food

Standard food is regulated for safety and composition but not required to demonstrate physiological effects. Claims about taste, cooking properties, or general nutritional content are permitted; therapeutic health claims are not. "Oily fish contains omega-3" is a compositional statement — acceptable. "Eating oily fish treats heart disease" would be an unauthorised therapeutic claim.

Dietary Supplement (Food Supplement)

Regulated under the Food Supplements Regulations 2003 as a food — not as a medicine. Key features:

• No pre-market efficacy proof required
• Safety is manufacturer's responsibility; the FSA can act post-market if safety concerns emerge
• Health claims must be from the EFSA-authorised list (UK retained the EU authorised claims register post-Brexit)
• Labelling must include: product name, quantity, dosage instructions, nutrient amounts, warning "Do not use as a substitute for a varied diet"

Medicine (Medicinal Product)

Regulated by the MHRA under the Human Medicines Regulations 2012. Features:

• Pre-market clinical trial data required (Phase I–III)
• Marketing authorisation (MA) required before sale
• Specific therapeutic claims permitted — "treats," "prevents," "cures"
• Post-market pharmacovigilance (adverse event reporting) mandatory
• Manufacturing to GMP (Good Manufacturing Practice) standard

The Borderline Problem

Many products exist at the boundary between supplement and medicine. The MHRA applies a dual test to classify borderline products:

1. Presentation test: Does the product claim to treat or prevent a disease?
2. Function test: Does the product actually have medicinal effects by pharmacological, immunological, or metabolic action at the proposed dose?

If either test is met, the MHRA can classify a supplement as a medicine and require it to go through the pharmaceutical licensing process.

Example: High-dose melatonin

• Melatonin 0.5mg as a food supplement for general sleep rhythm support: available as a supplement in some EU countries
• Melatonin 2mg slow-release (Circadin, Slenyto): MHRA-licensed medicine requiring prescription in UK for sleep onset disorders
• The same molecule, different dose and claim, different regulatory category

Example: Red yeast rice (containing monacolin K)

• Red yeast rice containing monacolin K >3mg/portion is considered by the MHRA/FSA to contain a substance with the same pharmacological activity as lovastatin (a prescription statin)
• Products with meaningful monacolin K content are therefore borderline between supplement and unlicensed medicine
• The EFSA issued a safety opinion in 2018 expressing concern about cardiovascular risks equivalent to statin side effects

Products That Frequently Create Consumer Confusion

Omega-3 Fatty Acids

• Food: Oily fish, enriched eggs
• Supplement: Standard fish oil capsules (providing ~300–1000mg EPA+DHA/day) — health claims for heart maintenance permitted at 250mg EPA+DHA/day
• Medicine: Prescription omega-3 (Omacor, providing 1g EPA+DHA in TG or EE form) — licensed for hypertriglyceridaemia and post-MI secondary prevention

The MHRA has clarified that omega-3 at doses used for adjunct therapy in hypertriglyceridaemia (4g/day or above) may be classified as medicinal. Standard supplement doses are firmly food supplements.

Vitamin D

• Supplement: 10–100 mcg/day cholecalciferol — widely available OTC
• Medicine: Alfacalcidol, calcitriol (activated vitamin D analogues) — prescription only for renal osteodystrophy and hypoparathyroidism
• High-dose OTC: Products above 100 mcg (4,000 IU)/day are not covered by the NHS recommendation and approach the tolerable upper intake level (100 mcg/day for adults); not illegal but outside routine supplement classification

Chromium and Blood Glucose

• Chromium picolinate as a food supplement can carry the EFSA-authorised claim for "normal macronutrient metabolism" — this is a nutrient function claim
• It cannot claim to "treat" or "prevent" diabetes — that would require a medicine classification
• The distinction matters: the authorised claim is based on normal physiological function, not a therapeutic effect in disease

What "Natural" Does Not Mean

Marketing language frequently uses "natural" to imply safety and regulatory approval. Neither is correct:

• Natural does not equal safe: Aristolochic acid (from Aristolochia plants) causes irreversible renal fibrosis; pyrrolizidine alkaloids (found in comfrey, borage, some herbal teas) are hepatotoxic; ephedra (ma huang) caused cardiovascular deaths and was banned
• Natural does not mean regulated: Herbal supplement manufacturing is not required to meet the same GMP standards as licensed medicines in most cases, and contamination, adulteration, and label inaccuracy are documented problems
• Natural does not equal evidence-based: "Natural" makes no claim about clinical trial support

The MHRA Traditional Herbal Registration (THR) scheme provides a middle path for traditional herbal medicines — requiring evidence of quality and traditional use, but not full clinical efficacy data.

Summary: What Category Means in Practice

For a consumer evaluating a supplement product: the category determines the burden of proof that was met before sale. A food supplement carries minimal pre-sale evidence burden. A licensed medicine carries substantial clinical evidence. When evaluating a supplement's health claim, the regulatory category tells you what standard the evidence was held to — often much lower than it might appear from the packaging.

Consumers who experience adverse effects from a supplement or believe a product is making unauthorised medical claims can report to the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk) or to Trading Standards via Citizens Advice.